Clinical trial
Safety Study of PI-0824 to Treat Pemphigus Vulgaris
NCT00063752 · Peptimmune, Industry · Completed
Key facts
| NCT number | NCT00063752 |
|---|---|
| Title | Safety Study of PI-0824 to Treat Pemphigus Vulgaris |
| Official title | An Open-Label, Dose-Escalation, Phase I Clinical Study to Assess the Safety of PI-0824 in Patient With Pemphigus Vulgaris Requiring Daily Corticosteroid Therapy |
| Lead sponsor | Peptimmune, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pemphigus Vulgaris |
| Intervention type | Drug |
| Interventions | PI-0824 |
| Enrollment | 15 |
| Start date | Jul 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Jul 8, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: